Overexpression or enhanced activity of Ago2 elicited specific changes in miRNAs and mRNAs and had a strong relationship with high-risk myeloma (Zhou et al., 2010; Hagiwara et al., 2012; Zhang et al., 2013). The gene discussed is AGO2; the disease is plasma cell myeloma.